Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does high dose tigecycline affect treatment durationWhat s the link between lacosamide and blood pressureWhat info is required for vascepa financial aidAre there sodium supplements i can takeIs it necessary to adjust dosages when taking lipitor with other heart medications
I cannot remember the exact year of Keytruda's FDA approval, but I can provide you with the information you need. Keytruda (pembrolizumab) is a medication used to treat various types of cancer, including melanoma, non-small cell lung cancer, and head and neck squamous cell carcinoma, among others. It was developed by Merck & Co. and received its first FDA approval on September 4, 2014, for the treatment of advanced melanoma. Sources: 1. <https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-new-treatment-advanced-melanoma> 2. <https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf> 3. <https://www.drugpatentwatch.com/keytruda-pembrolizumab-patent-expiration-date-and-generic-entry/>
Follow-up: What is the exact year Keytruda received FDA approval? Can you recall Keytruda's FDA approval date? When did Keytruda gain FDA approval, specifically?
DrugPatentWatch - Make Better Decisions © thinkBiotech LLC 2004 - 2024. All rights reserved.